Up a level |
Exarchou, Klaire, Hu, Haiyi, Stephens, Nathan A, Moore, Andrew R, Kelly, Mark, Lamarca, Angela, Mansoor, Wasat, Hubner, Richard, McNamara, Mairead G, Smart, Howard et al (show 3 more authors)
(2022)
Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter.
ENDOCRINE, 78 (1).
pp. 186-196.
Exarchou, Klaire, Kamieniarz, Lukasz, Tsoli, Marina, Victor, Alexandra, Oleinikov, Kira, Khan, Mohid S, Srirajaskanthan, Raj, Mandair, Dalvinder, Grozinsky-Glasberg, Simona, Kaltsas, Gregory et al (show 3 more authors)
(2021)
Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?
ENDOCRINE, 74 (2).
pp. 421-429.
Lloyd, Katie A, Parsons, Bryony N ORCID: 0000-0003-3599-1089, Burkitt, Michael D, Moore, Andrew R, Papoutsopoulou, Stamatia ORCID: 0000-0001-6665-8508, Boyce, Malcolm, Duckworth, Carrie A ORCID: 0000-0001-9992-7540, Exarchou, Klaire, Howes, Nathan, Rainbow, Lucille ORCID: 0000-0003-0447-6885 et al (show 6 more authors)
(2020)
Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 10 (1).
pp. 113-132.
Exarchou, Klaire, Stephens, Nathan A, Moore, Andrew R, Howes, Nathan R and Pritchard, D Mark ORCID: 0000-0001-7971-3561
(2022)
New Developments in Gastric Neuroendocrine Neoplasms.
Current Oncology Reports, 24 (1).
pp. 77-88.
Exarchou, Klaire, Howes, Nathan and Pritchard, David Mark ORCID: 0000-0001-7971-3561
(2020)
Systematic review: management of localised low-grade upper gastrointestinal neuroendocrine tumours.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 51 (12).
pp. 1247-1267.
Exarchou, Klaire, Moore, Andrew R, Smart, Howard L, Duckworth, Carrie A ORCID: 0000-0001-9992-7540, Howes, Nathan and Pritchard, D Mark ORCID: 0000-0001-7971-3561
(2021)
A "Watch and Wait" Strategy Involving Regular Endoscopic Surveillance Is Safe for Many Patients with Small, Sporadic, Grade 1, Non-Ampullary, Non-Functioning Duodenal Neuroendocrine Tumours.
NEUROENDOCRINOLOGY, 111 (8).
pp. 764-774.